A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Purpose of review In the past 20 years, several pathogen inactivation technologies have been developed to be applied to blood components. This review is intended to summarize the data currently available about the technologies and the clinical use of products inactivated by those techniques. Recent findings Technologies for inactivating pathogens in plasma and platelets are available, and are increasingly used in many countries. Cumulative experience over the last decade in routine use supportsdoi:10.1097/moh.0b013e328365a18f pmid:24104416 fatcat:vwb3glri5rf75c7wdybvbyzldq